Experimental studies show a decisive role of selenium in AD pathogenesis via abilities to reduce mitochondrial oxidative stress [60], to inhibit metal-induced Aβ aggregation [33] and to reduce Tau hyperphosphorylation [61,62]. Here, MAPT is linked to Alzheimer disease.